Monitor the August 5 EGM for the Axalta merger vote and any updates on regulatory approvals. The Russian deconsolidation (net asset value EUR 214M) will create a non-cash charge in Q3 but does not affect adjusted EBITDA. Watch for the Ichthys court ruling, which could result in a material cash outflow if AkzoNobel loses.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 22 $22.10entry
- T+1 · 4mo ago −3.67%α −2.43% · $21.29
- T+5 · 4mo ago +5.11%α +7.51% · $23.23
- T+20 · 3mo ago +6.74%α +3.85% · $23.59
- T+60 · 5w ago −0.32%α −3.84% · $22.03
Price Chart
How similar events traded
Executive Summary
AkzoNobel reported Q2 2026 results with total revenue down 1% YoY to EUR 2,589 million, but organic sales grew 2% driven by pricing. Adjusted EBITDA rose slightly to EUR 398 million (Q2 2025: EUR 393 million). The company is progressing toward its all-stock merger with Axalta, with an EGM scheduled for August 5, 2026. A subsequent event, Russian entities placed under temporary external administration, will result in deconsolidation and a non-cash charge, but the business represents less than 2% of revenue. Overall, the quarter showed stable underlying performance with pricing gains offsetting volume weakness and divestment headwinds, while the merger timeline and Russian exposure add uncertainty.
Key Facts
- Q2 2026 revenue was EUR 2,589 million, down 1% YoY (organic sales +2%)
- Adjusted EBITDA was EUR 398 million, up from EUR 393 million in Q2 2025
- Half-year 2026 revenue was EUR 4,975 million, down 5% YoY; adjusted EBITDA was EUR 743 million vs EUR 750 million
- Net income attributable to shareholders was EUR 232 million (H1 2026), flat vs EUR 231 million (H1 2025)
- Adjusted EPS from continuing operations was EUR 1.96 (H1 2026) vs EUR 2.07 (H1 2025)
- Net debt was EUR 3,127 million at June 30, 2026, up from EUR 2,942 million at year-end 2025; leverage ratio was 2.2x
- The all-stock merger with Axalta is proceeding; EGM on August 5, 2026; special dividend of EUR 2.5 billion conditional on closing
- Russian entities placed under temporary external administration on July 13, 2026; net asset value of EUR 214 million to be deconsolidated
- Project Ichthys litigation continues; INPEX seeks AUD 4.8 billion in damages; AkzoNobel has a EUR 300 million provision and EUR 500 million insurance coverage
Financial Impact
Q2 revenue EUR 2,589M (-1% YoY); adjusted EBITDA EUR 398M (+1%); H1 adjusted EPS EUR 1.96 (-5% YoY)
Risk Factors
- Adverse ruling in Project Ichthys litigation with potential damages up to AUD 4.8 billion
- Deconsolidation of Russian entities may lead to impairment or write-down of EUR 214 million net asset value
- Merger with Axalta may be delayed or terminated, triggering a EUR 150 million termination fee
- Raw material price inflation and geopolitical instability could pressure margins
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-311872 |
| Document: d10293d6k.htm | 0001193125-26-311872 |
| Document: 0001193125-26-311872-index-headers.html | 0001193125-26-311872 |
| Document: 0001193125-26-311872-index.html | 0001193125-26-311872 |
| Document: 0001193125-26-311872.txt | 0001193125-26-311872 |
Track record
14 reports on AKZOY
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +7.29% at T+20 after the Oct 5, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 12, 20264d ago 6-K Neutral 4/10 Entry $23.19 to $23.18 Now $22.90 −1.25% ▼ −0.04% +0.32% vs SPY
- Nov 6, 202610d ago 6-K Bullish 6/10 Entry $23.30 to $23.97 Now $22.90 −1.72% ▲ +2.88% +0.51% vs SPY
- Oct 21, 202626d ago 6-K Neutral 5/10 No price data
- Oct 21, 202626d ago 6-K Neutral 4/10 No price data
- Oct 21, 202626d ago 6-K Neutral 4/10 Entry $22.83 to $22.59 Now $22.90 +0.31% ▼ −1.05% +0.13% vs SPY
- Oct 16, 20264w ago 6-K Neutral 4/10 Entry $22.03 to $21.95 Now $22.90 +3.95% ▼ −0.36% −0.79% vs SPY
- Oct 15, 20264w ago 6-K Neutral 3/10 Entry $22.03 to $21.95 Now $22.90 +3.95% ▼ −0.36% −0.79% vs SPY
- Oct 5, 20266w ago 6-K Bullish 6/10 Entry $21.53 to $21.87 Now $22.90 +6.36% ▲ +1.58% +1.03% vs SPY
- Aug 31, 202611w ago 6-K Neutral 3/10 Entry $23.91 to $23.07 Now $22.90 −4.22% ▼ −3.51% −2.83% vs SPY
- Jul 23, 202616w ago 6-K Neutral 3/10 Entry $21.28 to $21.93 Now $22.90 +7.61% ▲ +3.05% +2.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers